Ordering is easy just reach out to us and well guide you through the simple process
Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
So, the more blood vessels formed due to BPC-157, the more efficiently blood, nutrients, and oxygen are delivered to the injured sites, leading to quicker recovery
Work with a qualified clinician before initiating any peptide therapy
We help tailor frequency based on how you feel and what you want to support long term
